Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm: a Randomized, Triple-blind, Placebo-controlled, Cross-over Clinical Trial

NCT03508882 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT03508882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03508882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm: a Randomized, Triple-blind, Placebo-controlled, Cross-over Clinical Trial
Lead sponsor
The University of Hong Kong
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2015
Completion date
February 20, 2019
Enrollment
100 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

blepharospasm, botulinum toxins, type a, hemifacial spasm